Commercialized a highly effective skin cancer scanning device

Used for over 12 years and supported by more than 15 published clinical studies

Sponsored
Message: End Of Year Financials

I think your reasoning is sound however the issue is we partnered with another telemedicine platform at the time and they are still using our original SIAscopes in these locations. We would have to go into their market and dislocate their platform which would cause a host of legal breaches. It is easier for MedX to use the findings from the research paper;  https://www.sciencedirect.com/science/article/pii/S1551741116305812

as the  "proof of concept" of acceptance of this modality and enter similar markets. In Brazil, Mexico we a deeply focused on using the pharmacies as "ease of access" locations. We are also heavily engaged in Canada and the USA with major pharmacy chains and hope to have news regarding our progress shortly.

Share
New Message
Please login to post a reply